Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormonal contraception and epilepsy.

A Guberman1

  • 1University of Ottawa, the Ottawa Hospital, Ontario, Canada.

Neurology
|September 16, 1999
PubMed
Summary
This summary is machine-generated.

Women with epilepsy can use oral contraceptives (OCs) for reliable birth control. Estrogen in OCs may not worsen seizures, but drug interactions with antiepileptic drugs (AEDs) require careful OC selection and counseling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro developmental competence of bovine demi-embryos generated by blastomere separation and blastocyst bisection.

Reproduction in domestic animals = Zuchthygiene·2024
Same author

Fibrous dysplasia of the skull base presenting acutely in an adult.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2006
Same author

Are there potential problems with generic substitution of antiepileptic drugs? A review of issues.

Seizure·2006
Same author

Low-dose topiramate in adults with treatment-resistant partial-onset seizures.

Acta neurologica Scandinavica·2002
Same author

Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 800 mg/day) in a B.I.D. regimen.

Seizure·2002
Same author

Screening for and characterization of phospholipase A1 hypersecretory mutants of Tetrahymena thermophila.

Applied microbiology and biotechnology·2000
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Gynecology
  • Pharmacology

Background:

  • Epilepsy management requires lifestyle normalization and quality of life optimization.
  • Reliable contraception, including oral contraceptives (OCs), is crucial for women with epilepsy.
  • Estrogen's pro-convulsant effects are known, but OC-induced seizure worsening in epilepsy is not established.

Purpose of the Study:

  • To evaluate the safety and efficacy of oral contraceptives (OCs) in women with epilepsy.
  • To provide guidance on selecting appropriate OCs for epileptic patients.
  • To inform physicians about potential drug interactions between OCs and antiepileptic drugs (AEDs).

Main Methods:

  • Review of existing literature on estrogen and progesterone effects on seizure threshold.

Related Experiment Videos

  • Analysis of evidence regarding OC failure rates when co-administered with AEDs.
  • Formulation of recommendations for OC use in women with epilepsy based on AED-induced enzyme activity.

    • Main Results:

    • Estrogen-containing OCs have not been proven to worsen seizures in epileptic patients.
    • Progesterone in OCs might counteract estrogen's pro-convulsant effects.
    • AEDs can induce hepatic enzymes, potentially reducing the efficacy of OCs by increasing endogenous estradiol and progesterone metabolism.

    Conclusions:

    • Physicians must counsel epileptic patients on optimal OC selection.
    • For patients on enzyme-inducing AEDs, OCs with ≥50 mcg estrogen or non-inducing AEDs are recommended.
    • Midcycle bleeding signals potential OC failure; absence of bleeding does not guarantee effectiveness. Additional contraception is advised.